+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses



Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses



Antimicrobial Agents and ChemoTherapy 60(3): 1615-1626



Antiviral drugs do not currently exist for the treatment of enterovirus infections, which are often severe and potentially life-threatening. We conducted high-throughput molecular screening and identified a structurally diverse set of compounds that inhibit the replication of coxsackievirus B3, a commonly encountered enterovirus. These compounds did not interfere with the function of the viral internal ribosome entry site or with the activity of the viral proteases, but they did drastically reduce the synthesis of viral RNA and viral proteins in infected cells. Sequence analysis of compound-resistant mutants suggests that the viral 2C protein is targeted by most of these compounds. These compounds demonstrated antiviral activity against a panel of the most commonly encountered enteroviruses and thus represent potential leads for the development of broad-spectrum anti-enteroviral drugs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057633690

Download citation: RISBibTeXText

PMID: 26711750

DOI: 10.1128/aac.02646-15


Related references

High-throughput small molecule screening reveals structurally diverse compounds that inhibit the growth of Escherichia coli O157:H7 in vitro. Journal of Food Protection 74(12): 2148-2156, 2012

Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts. Journal of Clinical Virology 37(Suppl. 1): S69-S75, 2007

Identification of an antioxidant small-molecule with broad-spectrum antiviral activity. Antiviral Research 93(1): 23-29, 2012

Small-molecule activators of RNase L with broad-spectrum antiviral activity. Proceedings of the National Academy of Sciences of the United States of America 104(23): 9585-9590, 2007

Small-molecule immunostimulants: Synthesis and activity of 7,8-disubstituted guanosines and structurally related compounds. Journal of Medicinal Chemistry 37(21): 3561-3578, 1994

Discovery of diverse small molecule chemotypes with cell-based PKD1 inhibitory activity. Plos One 6(10): E25134, 2012

Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119. Assay and Drug Development Technologies 16(5): 278-288, 2018

Discovery of a Structurally Unique Small Molecule that Inhibits Protein Synthesis. Yale Journal of Biology and Medicine 90(1): 35-43, 2017

In vitro activity of new antiviral compounds note 2. investigations with enteroviruses and rhinovirus 1 b. Revue Roumaine de Medecine Virologie 36(2): 111-117, 1985

In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Antiviral Research 84(3): 234-241, 2010

Synthesis and antiviral activity of 1 beta d ribofuranosyl 1 2 4 triazole 3 sulfonamide and certain related compounds as a congeners of the broad spectrum antiviral agent ribavirin. Abstracts of Papers Chemical Congress of North America 3(2): MEDI 12, 1988

Discovery of a small-molecule antiviral targeting the HIV-1 matrix protein. Bioorganic and Medicinal Chemistry Letters 23(4): 1132-1135, 2013

Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds. Pharmaceutical Research (new York). 15(9): 1490-1494,., 1998

Synthesis and Broad Antiviral Activity of Novel 2-aryl-isoindolin-1-ones towards Diverse Enterovirus A71 Clinical Isolates. Molecules 24(5), 2019

Antiviral agents 3. Discovery of a novel small molecule non-nucleoside inhibitor of hepatitis B virus (HBV). Bioorganic and Medicinal Chemistry Letters 21(6): 1644-1648, 2011